We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Therapeutic Goods Act 1989
Approval under section 42DF for use of restricted representations by Australasian Medical & Scientific Ltd
I, Rowena Love, as a delegate of the Secretary to the Department of Health and Aged Care, on receipt of an application from Australasian Medical & Scientific Ltd, have approved under section 42DF of the Therapeutic Goods Act 1989, the restricted representations described in paragraph (A), for use in advertisements for the product identified in paragraph (B), subject to the conditions identified in paragraph (C).
(A)
- Help manage your diabetes with the Tandem Diabetes Care mobile app
- For people living with diabetes
- For people with diabetes
- Allows people living with diabetes to bolus right from their phone.
(B)
- Tandem Diabetes Care mobile app - Ambulatory insulin infusion pump software, patient-dosing (ARTG 462547).
(C)
- Advertisements in which any one of the restricted representations described in paragraph (A) is used must comply with the Therapeutic Goods Advertising Code (the Code).
Dated this 14th day of April 2025
Signed electronically
Rowena Love
Delegate of the Secretary to the Department of Health and Aged Care
Advertising and Compliance Education and Policy Section
Regulatory Compliance Branch